200 College Avenue
Medford
MA 02155
Signal Processing Society, Education Society and Women In Engineering
On Behalf of Dr. Karen A. Panetta, Dean of Graduate Education for the School of Engineering
We are pleased to announce this special event:
Lecture by:
Dr. Christalyn Rhodes
All are invited to attend. Exceptional Leaders in STEM is a lecture series, exploring themes related to leaders in STEM fields.
Dinner will be served at 6:00 pm, program begins at 6:30 pm, in-person and on zoom.
Registration saves your seat for the in-person event. Please notify our office at least 24 hours in advance if you must cancel for any reason, so that we can reduce the food order. Thank you for your cooperation.
To see more information and to register for the event, click above link, scan the QR code, or enter URL: https://tufts.qualtrics.com/jfe/form/SV_20toHjT6QdVq9xk
Dr. Rhodes is a scientist, inventor and entrepreneur. She is a pioneering biotech innovator and strategist responsible for the innovation strategies at 3 VC funded biotech startups. She originated and advised a range of companies including those that design therapeutics that address diseases that carry a high economic burden as well as those that develop new funding strategies to address disparities in healthcare cost. She designed the technology and authored pivotal patents that changed the trajectory of previously failing companies and projects amounting to a savings of more than $50 million dollars.
Dr. Rhodes is currently the Associate Vice President- Genetic Medicine, External Partnerships and Academic Collaborations for Eli Lilly and company where she identifies opportunities, manages deals and innovates nuanced approaches to developing medicine and delivering healthcare. She supported Eli Lilly’s de-centralized clinical trials for COVID with on-the-ground operations in key southern states. Additionally, Christalyn serves as the expert-in-residence for Harvard Innovation Labs where she has advised a number of startups ranging from idea stage and brainstorming to securing funding.
Previously, Christalyn worked as a venture capital associate for Flagship Pioneering where she co-founded a biotechnological platform company to create novel therapeutics in the space of personalized genomic medicine.
Dr. Rhodes received a Ph.D. in Biological Sciences from Harvard University and a BA from the University of North Texas. She has been a visiting researcher at the University of Wisconsin-Madison School of Medicine and Public Health. Dr. Rhodes has been a speaker and mentor for the Harvard Medical School Biomedical Science Career Program, Morehouse School of Medicine, Nucleate and others working to recruit and train next-generation translational scientists.
ACCOMPLISHMENTS:
- Expert-in-residence-Harvard University (Innovation Lab)
- Harvard Horizons Scholar
- Inventor-Multiple patents on platform drug development technologies
- Board Member-UMASS medical bridge fund
- Board Member-Harvard Medical School, Beth-Isreal Deaconess Initiative for RNA Medicine
- Harvard Kenneth C. Griffin Graduate School for Arts and Science (GSAS)-Council Member, Co-Chair for student life
- Advisor-Nucleate (501c3)
COMPANIES FOUNDED:
- Founder ARC Therapeutics– a novel drug discovery platform company using soft matter physics techniques to develop medicines
- Co-founder/Inventor- FL64(A Flagship Pioneering company) acquired– a novel drug discovery platform focused on transcriptome editing medicines
- Founder State Fair-an AI technology in biotech company pionerring health equity indicies (Bloomberg Ticker- FAIR)